Uncomplicated Urinary Tract Infection
Young female presents with acute onset dysuria, urinary frequency/urgency. Pt recently became sexually active for the first time. Denies change in urine appearance/odor. Denies chills, rigors, marked increase in fatigue. Denies h/o confirmed multidrug resistant UTI. Afebrile with no suprapubic tenderness on exam; no costovertebral angle tenderness.
Urine dipstick positive for leukocyte esterase, nitrites
Obtain urine pregnancy test, urine culture
Pregnancy test negative: Start nitrofurantoin 100 mg BID x5 days and adjust antibiotic therapy pending culture
Notes
Symptom interpretation
Change in urine color/smell is not specific for UTI and should not prompt further workup in the absence of other symptoms
Women who self-diagnose UTI have a 85% positive culture rate; this is more accurate than dipstick testing
Dipstick interpretation
Leukocyte esterase: 75% sensitivity, 98% specificity
Nitrites: 30% sensitivity, 90% specificity
Cranberry products are not effective in relieving symptoms
Pregnancy considerations
Antibiotics
Fosfomycin 3 g as a single dose is safe in all three trimesters, but may have decreased efficacy compared to other first-line agents (IDSA 2018)
Nitrofurantoin is safe in the 2nd and 3rd trimesters
TMP-SMX is contraindicated
Perform test of cure 1 week after starting therapy
Acute, Complicated Urinary Tract Infection
Elderly male with h/o indwelling Foley catheter and repeat UTIs presents with new onset urinary frequency/urgency in the setting of increased debility. Caretaker reports recent chills, rigors, flank pain. Fever, altered mental status, abdominal/suprapubic tenderness, costovertebral angle tenderness on exam.
Labs
Obtain CBC, BMP, urine/blood cultures
Dipstick positive for leukocyte esterase, nitrites
Urinalysis positive for pyuria, bacteria
Consider abdominal/pelvic CT with and without contrast in the following scenarios:
Patient meets sepsis criteria
Symptoms do not improve after 72 hours of antibiotic therapy
Admit for inpatient management if the patient meet any of the following criteria:
Debility and/or marked change in overall health status
Fever >38.4
Pt requires IV antibiotic therapy, e.g.
Inability to maintain PO hydration and/or tolerate PO therapy
Treatment with IV agent indicated (see below)
Antibiotic therapy
Meropenem 1 g IV q8 hours x 10 days for any of the following:
History of infection with multidrug-resistant organism
Long term care facility resident or recent hospitalization
Treatment with broad spectrum beta-lactam, TMP-SMX or fluoroquinolone within the past week
Otherwise start ceftriaxone 1 g IV daily x 10 days; transition to cefdinir (Omnicef) 300 mg BID and complete course once pt can tolerate PO intake
Adjust antibiotic therapy pending culture sensitivities
Notes
Complicated UTI includes infections extending beyond the bladder, e.g. pyelonephritis
Clinical definition: One of the following must apply
Fever + s/sx systemic illness, e.g. new onset debility, chills/rigors
Pyuria + one of the following
Flank pain/CVA tenderness or imaging indicating pyelonephritis
Fever and/or sepsis
Dipstick interpretation
Leukocyte esterase: 75% sensitivity, 98% specificity
Nitrites: 30% sensitivity, 90% specificity
Microbiology/urine culture
Most commonly associated bacterial pathogens are nitrite producing and include E. coli, Klebsiella, and Proteus species
Positive if >100,000 bacterial colony forming units present
Diagnostic reference: Urinalysis Evidence Based Summary